17-73197258-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018714.3(COG1):​c.775G>T​(p.Val259Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000715 in 1,614,224 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 3 hom. )

Consequence

COG1
NM_018714.3 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.27

Publications

0 publications found
Variant links:
Genes affected
COG1 (HGNC:6545): (component of oligomeric golgi complex 1) The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. It is thought that this protein is required for steps in the normal medial and trans Golgi-associated processing of glycoconjugates and plays a role in the organization of the Golgi-localized complex. [provided by RefSeq, Jul 2008]
COG1 Gene-Disease associations (from GenCC):
  • COG1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, PanelApp Australia, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008938342).
BP6
Variant 17-73197258-G-T is Benign according to our data. Variant chr17-73197258-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 235502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00389 (592/152330) while in subpopulation AFR AF = 0.0137 (569/41572). AF 95% confidence interval is 0.0128. There are 3 homozygotes in GnomAd4. There are 268 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG1NM_018714.3 linkc.775G>T p.Val259Leu missense_variant Exon 4 of 14 ENST00000299886.9 NP_061184.1 Q8WTW3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG1ENST00000299886.9 linkc.775G>T p.Val259Leu missense_variant Exon 4 of 14 1 NM_018714.3 ENSP00000299886.4 Q8WTW3
COG1ENST00000438720.7 linkc.772G>T p.Val258Leu missense_variant Exon 4 of 13 1 ENSP00000400111.3 E9PBL8
COG1ENST00000582587.2 linkn.*543G>T downstream_gene_variant 3 ENSP00000462101.1 J3KRP4

Frequencies

GnomAD3 genomes
AF:
0.00391
AC:
595
AN:
152212
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000942
AC:
237
AN:
251492
AF XY:
0.000662
show subpopulations
Gnomad AFR exome
AF:
0.0139
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000384
AC:
562
AN:
1461894
Hom.:
3
Cov.:
35
AF XY:
0.000311
AC XY:
226
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0145
AC:
485
AN:
33480
American (AMR)
AF:
0.000380
AC:
17
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1112012
Other (OTH)
AF:
0.000712
AC:
43
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00389
AC:
592
AN:
152330
Hom.:
3
Cov.:
33
AF XY:
0.00360
AC XY:
268
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0137
AC:
569
AN:
41572
American (AMR)
AF:
0.000980
AC:
15
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68020
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00102
Hom.:
12
Bravo
AF:
0.00411
ESP6500AA
AF:
0.0148
AC:
65
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00120
AC:
146
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 04, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COG1 congenital disorder of glycosylation Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.0039
T;T
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.88
D;D
MetaRNN
Benign
0.0089
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
.;M
PhyloP100
6.3
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.65
.;N
REVEL
Benign
0.11
Sift
Benign
0.20
.;T
Sift4G
Benign
0.52
T;T
Polyphen
0.13
.;B
Vest4
0.37
MutPred
0.42
Loss of glycosylation at T264 (P = 0.5412);Loss of glycosylation at T264 (P = 0.5412);
MVP
0.35
MPC
0.22
ClinPred
0.036
T
GERP RS
5.8
Varity_R
0.095
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139304974; hg19: chr17-71193397; API